Short Interfering RNA Directed against the SLUG Gene Increases Cell Death Induction in Human Melanoma Cell Lines Exposed to Cisplatin and Fotemustine

Short Interfering RNA Directed against the SLUG Gene Increases Cell Death Induction in Human Melanoma Cell Lines Exposed to Cisplatin and Fotemustine

Background: Melanoma remains largely resistant to currently available chemotherapy, and new strategies have been proposed to flank standardized therapeutic protocols in an effort to improve efficacy. Such an approach requires good knowledge of the mechanisms involved in the resistance and survival o...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Ivan Vannini, Massimiliano Bonafe, Anna Tesei, Marco Rosetti, Francesco Fabbri, Gianluca Storci, Paola Ulivi, Giovanni Brigliadori, Dino Amadori, Wainer Zoli
Natura:	Articolo
Lingua:	English
Pubblicazione:	Hindawi Limited 2007-01-01
Serie:	Cellular Oncology
Accesso online:	http://dx.doi.org/10.1155/2007/540821

Documenti analoghi

Study of molecular mechanisms of pro-apoptotic activity of NCX 4040, a novel nitric oxide-releasing aspirin, in colon cancer cell lines
di: Vannini Ivan, et al.
Pubblicazione: (2007-10-01)

<it>In vitro </it>and <it>in vivo </it>evaluation of NCX 4040 cytotoxic activity in human colon cancer cell lines
di: Zupi Gabriella, et al.
Pubblicazione: (2005-02-01)

Inhibition of breast cancer cell proliferation in repeated and non-repeated treatment with zoledronic acid
di: Ibrahim Toni, et al.
Pubblicazione: (2012-11-01)

Sequential events of apoptosis involving docetaxel, a microtubule-interfering agent: A cytometric study
di: Lapalombella Rosa, et al.
Pubblicazione: (2006-01-01)

Sensitivity of Zebrafish Embryogenesis to Risk of Fotemustine Exposure
di: Davide Di Paola, et al.
Pubblicazione: (2022-03-01)

Cellular Basis of Antiproliferative and Antitumor Activity of the Novel Camptothecin Derivative, Gimatecan, in Bladder Carcinoma Models
di: Paola Ulivi, et al.
Pubblicazione: (2005-02-01)

miRNAs as Non-Invasive Biomarkers for Lung Cancer Diagnosis
di: Paola Ulivi, et al.
Pubblicazione: (2014-06-01)

Effects of fotemustine or dacarbasine on a melanoma cell line pretreated with therapeutic proton irradiation
di: Privitera Giuseppe, et al.
Pubblicazione: (2009-04-01)

Biweekly fotemustine schedule for recurrent glioblastoma in the elderly: activity and toxicity assessment of a multicenter study
di: Raffaele Addeo, et al.
Pubblicazione: (2019-06-01)

Upfront Bevacizumab and Temozolomide or Fotemustine before Radiotherapy for Patients with Glioblastoma and Severe Neurological Impairment at Diagnosis
di: Celina Bihan, et al.
Pubblicazione: (2012-09-01)

Treatment of recurrent malignant gliomas with fotemustine monotherapy: impact of dose and correlation with MGMT promoter methylation
di: Mirri Maria, et al.
Pubblicazione: (2009-03-01)

Predictive role of multiple gene alterations in response to cetuximab in metastatic colorectal cancer: A single center study
di: Ulivi Paola, et al.
Pubblicazione: (2012-05-01)

Interfering with the expression of EEF1D gene enhances the sensitivity of ovarian cancer cells to cisplatin
di: Qia Xu, et al.
Pubblicazione: (2022-06-01)

Epigenetic control of the basal-like gene expression profile via Interleukin-6 in breast cancer cells
di: Mitrugno Valentina, et al.
Pubblicazione: (2010-11-01)

Peritoneal carcinomatosis from ovarian cancer: chemosensitivity test and tissue markers as predictors of response to chemotherapy
di: Turci Livia, et al.
Pubblicazione: (2011-06-01)

Multiple marker detection in peripheral blood for NSCLC diagnosis.
di: Paola Ulivi, et al.
Pubblicazione: (2013-01-01)

High activity of sequential low dose chemo-modulating Temozolomide in combination with Fotemustine in metastatic melanoma. A feasibility study
di: Giudice Giuseppe, et al.
Pubblicazione: (2010-11-01)

HPV DNA Associates With Breast Cancer Malignancy and It Is Transferred to Breast Cancer Stromal Cells by Extracellular Vesicles
di: Sabrina De Carolis, et al.
Pubblicazione: (2019-09-01)

Mubritinib enhanced the inhibiting function of cisplatin in lung cancer by interfering with mitochondrial function
di: Jingyao Dong, et al.
Pubblicazione: (2022-05-01)

EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer
di: Haslehurst Alexandria M, et al.
Pubblicazione: (2012-03-01)

Genomic alterations in rectal tumors and response to neoadjuvant chemoradiotherapy: an exploratory study
di: Molinari Chiara, et al.
Pubblicazione: (2011-11-01)

Enhanced Cisplatin Cytotoxicity by RNA Interfering the Excision Repair Cross-complementing Gene 1 in Lung Cancer Cell A549/DDP
di: Yun GAO, et al.
Pubblicazione: (2010-09-01)

Randomized phase II study with two gemcitabine- and docetaxel-based combinations as first-line chemotherapy for metastatic non-small cell lung cancer
di: Zoli Wainer, et al.
Pubblicazione: (2008-10-01)

Effect of small molecules modulating androgen receptor (SARMs) in human prostate cancer models.
di: Anna Tesei, et al.
Pubblicazione: (2013-01-01)

TP53 drives abscopal effect by secretion of senescence-associated molecular signals in non-small cell lung cancer
di: Anna Tesei, et al.
Pubblicazione: (2021-03-01)

Predictive Role of Telomerase Activity in the Clinical Outcome of Patients with Benign Lesions of the Uterine Cervix or CIN
di: Sara Bravaccini, et al.
Pubblicazione: (2012-01-01)

Interfering lncRNA XIST inhibits the growth of salivary adenoid cystic carcinoma cells and improves cisplatin sensitivity by up-regulating miR-429
di: Zhang Xuan, Ma Licheng, Sun Longxiao, Zhang Lei
Pubblicazione: (2022-07-01)

Phase II study of gemcitabine, doxorubicin and paclitaxel (GAT) as first-line chemotherapy for metastatic breast cancer: a translational research experience
di: Maltoni Roberta, et al.
Pubblicazione: (2006-03-01)

Slug flow
di: Griffith, P., et al.
Pubblicazione: (2011)

Hinokitiol inhibits Aspergillus fumigatus by interfering with the cell membrane and cell wall
di: Fanyue Meng, et al.
Pubblicazione: (2023-04-01)

Reciprocal expression of Slug and Snail in human oral cancer cells.
di: Ryosuke Nakamura, et al.
Pubblicazione: (2018-01-01)

The prevention of disease relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia
di: Enrico Maffini, et al.
Pubblicazione: (2022-11-01)

Slug Mediates MRP2 Expression in Non-Small Cell Lung Cancer Cells
di: Xieyi Zhang, et al.
Pubblicazione: (2022-06-01)

Slug-expressing mouse prostate epithelial cells have increased stem cell potential
di: Zuzana Kahounová, et al.
Pubblicazione: (2020-07-01)

The Suppression of Multidrug Resistance in Leukemic Cells by Short Interfering RNA
di: Fatemeh Nadali, et al.
Pubblicazione: (2009-07-01)

Interfering with water
di: Clary, D
Pubblicazione: (1999)

Interfering with transmission
di: Andreas Wack
Pubblicazione: (2018-05-01)

Slug and Sox9 Cooperatively Determine the Mammary Stem Cell State
di: Guo, Wenjun, et al.
Pubblicazione: (2014)

KLF4, Slug and EMT in Head and Neck Squamous Cell Carcinoma
di: Julia Ingruber, et al.
Pubblicazione: (2021-03-01)

Fibronectin Regulation of Integrin B1 and SLUG in Circulating Tumor Cells
di: Jeannette Huaman, et al.
Pubblicazione: (2019-06-01)